On 29 March 2012, the European Parliament adopted the legislative proposal for a regulation on OTC derivatives, central counterparties and trade repositories (see “Update Banking & Finance”, Issue 5, November 2011). The purpose of the regulation is to apply a strict regulatory regime to derivatives traded “over the counter” (OTC), comprising clearing obligations, reporting requirements and authorisation for central counterparties. In parallel with work on creating a European regulatory framework, the USA has introduced similar rules for OTC derivatives via the Dodd-Frank Wall Street Reform and Consumer Protection Act. A comprehensive presentation and comparison of the two systems is provided here: http://www.cmshs. com/Neue_Regulierung_OTCDerivate_ 0512
Register Now As you are not an existing subscriber please register for your free daily legal newsfeed service.Register
If you have any questions about the service please contact email@example.com or call Lexology Customer Services on +44 20 7234 0606.
New regulation of oOTC derivatives in the EU and the US – European Market Infrastructure Regulations (EMIR)
- CMS Hasche Sigle
- Axel Dippmann , Alexander Schmitt, M.Jur. (Oxon) and Dr Sabrina Salewski, LL. M.
- European Union
- May 31 2012
If you are interested in submitting an article to Lexology, please contact Andrew Teague at firstname.lastname@example.org.
“The Lexology newsfeed is very relevant to my practice and I like that you can tailor the newsfeed to include specific practice areas. I enjoy seeing a variety of approaches and I will read multiple articles on the...
“The Lexology newsfeed is very relevant to my practice and I like that you can tailor the newsfeed to include specific practice areas. I enjoy seeing a variety of approaches and I will read multiple articles on the same topic for the purpose of getting the fullest understanding of a new law, a court case or other legal development.”
Audrey E Mross
Labor & Employment Attorney
Munck Carter LLP